pe
pep-05149 v1 CC-BY-SA-4.0

Neuromedin-B metabolic peptide

An experimental peptide that switches on the same body signal as today's diabetes and weight-loss shots; still in research, not an approved medicine.

statuscomputed targetGLP-1R length32 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.672
pTM0.845
avg pLDDT67.6
ranking score0.675
STRUCTURE · PEP-05149 × GLP-1R
ranking0.675
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence32 aa
15101520253032
APFNWDLPEPRSRASK IRVHPRGNLWATGHFM
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.6721004247665405 boltz-2
ranking score 0.675067126750946 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.980global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Ala-Pro-Phe-Asn-Trp-Asp-Leu-Pro-Glu-Pro-Arg-Ser-Arg-Ala-Ser-Lys-Ile-Arg-Val-His-Pro-Arg-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Neuromedin-B metabolic peptide (pep-05149, v1). PeptideModel. https://peptidemodel.com/card/pep-05149
@peptide{pep05149,
  sequence = {APFNWDLPEPRSRASKIRVHPRGNLWATGHFM},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use